Mechanisms of hepatitis C virus escape from vaccine-relevant neutralizing antibodies

10Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Hepatitis C virus (HCV) is a major causative agent of acute and chronic hepatitis. It is estimated that 400,000 people die every year from chronic HCV infection, mostly from severe liver-related diseases such as cirrhosis and liver cancer. Although HCV was discovered more than 30 years ago, an efficient prophylactic vaccine is still missing. The HCV glycoprotein complex, E1/E2, is the principal target of neutralizing antibodies (NAbs) and, thus, is an attractive antigen for B-cell vaccine design. However, the high genetic variability of the virus necessitates the identification of conserved epitopes. Moreover, the high intrinsic mutational capacity of HCV allows the virus to continually escape broadly NAbs (bNAbs), which is likely to cause issues with vaccine-resistant variants. Several studies have assessed the barrier-to-resistance of vaccine-relevant bNAbs in vivo and in vitro. Interestingly, recent studies have suggested that escape substitutions can confer antibody resistance not only by direct modification of the epitope but indirectly through allosteric effects, which can be grouped based on the breadth of these effects on antibody susceptibility. In this review, we summarize the current understanding of HCV-specific NAbs, with a special focus on vaccine-relevant bNAbs and their targets. We highlight antibody escape studies pointing out the different methodologies and the escape mutations identified thus far. Finally, we analyze the antibody escape mechanisms of envelope protein escape substitutions and polymorphisms according to the most recent evidence in the HCV field. The accumulated knowledge in identifying bNAb epitopes as well as assessing barriers to resistance and elucidating relevant escape mechanisms may prove critical in the successful development of an HCV B-cell vaccine.

References Powered by Scopus

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

2493Citations
N/AReaders
Get full text

Virology: Complete replication of hepatitis C virus in cell culture

2011Citations
N/AReaders
Get full text

Robust hepatitis C virus infection in vitro

1558Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1

8Citations
N/AReaders
Get full text

Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies

7Citations
N/AReaders
Get full text

Evaluation of interactions between the hepatitis C virus NS3/4A and sulfonamidobenzamide based molecules using molecular docking, molecular dynamics simulations and binding free energy calculations

5Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Velázquez-Moctezuma, R., Augestad, E. H., Castelli, M., Olesen, C. H., Clementi, N., Clementi, M., … Prentoe, J. (2021, March 1). Mechanisms of hepatitis C virus escape from vaccine-relevant neutralizing antibodies. Vaccines. MDPI AG. https://doi.org/10.3390/vaccines9030291

Readers over time

‘21‘22‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

63%

Researcher 4

25%

Professor / Associate Prof. 2

13%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 8

42%

Immunology and Microbiology 6

32%

Medicine and Dentistry 3

16%

Pharmacology, Toxicology and Pharmaceut... 2

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0